When the corona is over, clinical trials are significantly reduced…Global international clinical trials are in decline
Although Korea’s clinical trials fared well in terms of global share despite the decline from the endemic, the challenge of international clinical growth remained. At a time when fostering the domestic biopharmaceutical industry has emerged as a hot topic, he believes that international clinical trials are essential during the growth period to strengthen competitiveness, such […]
Astellas Beoza menopause treatment completed, FDA approved
Treatment of menopausal symptoms Astellas Pharmaceuticals Veoza (Fezolinetant) can launch in the US market after extending the review period. Astellas Veoja product photo The US Food and Drug Administration (FDA) announced on the 12th (local time) that Astellas Pharmaceuticals has approved Veozah, a new drug for the treatment of hot flashes (hot flashes) caused by […]
Core patent strategy for drug development… How to gain an advantage?
As the domestic biopharmaceutical industry moves forward into the global market, responding to patents, which is a prerequisite for challenging original treatments, is being emphasized. In addition to this, new drug development incorporating digital technology and responses to the global development of domestic innovative drugs has become a necessity, not an option. Experts believe that […]
Core patent strategy for drug development… How to gain an advantage?
As the domestic biopharmaceutical industry moves forward into the global market, responding to patents, which is a prerequisite for challenging original treatments, is being emphasized. In addition to this, new drug development incorporating digital technology and responses to the global development of domestic innovative drugs has become a necessity, not an option. Experts believe that […]
Emphasis on IQVIA Bio Korea surprise booth as a biopharmaceutical partner
“I came out to raise awareness of IQVIA and publicize its role as a partner at a time when Korea’s biopharmaceutical industry is growing.” IQVIA Korea, a company specializing in clinical and data development, participated in BIOKOREA 2023 for the first time this year and is actively communicating with the domestic biopharmaceutical industry. As more […]
Surprise booth at IQVIA Bio Korea… Emphasis on biopharma partners
“I came out to raise awareness of IQVIA and publicize its role as a partner at a time when Korea’s biopharmaceutical industry is growing.” IQVIA Korea, a company specializing in clinical and data development, participated in BIOKOREA 2023 for the first time this year and is actively communicating with the domestic biopharmaceutical industry. As more […]
5cm mayflies appear when you spread your wings, “The night is scary” in the neighborhood
A group of eastern mayflies flocked to the convenience store window in search of the light. / Provided by Namyangju City Recently, large swarms of mayflies have swarmed into the Seongsu-dong area of Seoul every night, causing residents to suffer. The ‘oriental ephemera’ is 5 cm long when its wings spread, and residents complain of […]
The Land of Opportunity Opened by Biosimilars… K-Bio Pridd
As domestic biosimilar companies stand out in the global market, expectations are rising as to whether they will be able to become a stepping stone for the revitalization of K-Bio. Experts are also paying attention to the value of biosimilars as an element of the bio-industry ecosystem beyond cost savings and benefits for patients. As […]
Genome & Company appoints Hong Yoo-seok, former CEO of GSK
Hong Yoo-seok, the new general manager of Genome & Company Genome & Company, a new microbiome-based drug development company, announced on the 8th that it has appointed Yoo-seok Hong as its general representative. Genome & Company plans to go through the process of appointing Hong Yoo-seok as the new CEO through the regular meeting of […]
Biosimilars are the future power of K-Bio… take your chance now
As financial savings and patient benefits, such as health insurance, emerge as major issues domestically and globally, biosimilars that have the same effect as the original and are cheaper are expanding their presence. In addition, a flood of biosimilars is predicted due to the expiration of patents for major treatments, and endless competition in the […]
